CombiGene signs production agreement with Spanish gene therapy manufacturer Viralgen
September 3, 2020
After having carried out a successful pilot production of CG01 in July at the Spanish gene
After having carried out a successful pilot production of CG01 in July at the Spanish gene
CombiGene AB (publ) (“CombiGene” or the “Company”) has today decided to carry out a directed share
CombiGene AB (publ) (”CombiGene” or the ”Company”) has today resolved to conduct a private placement of
The Board of Directors in Combigene AB (“Combigene” or the “Company”), reg. no. 556403-3818, has today,
Collaboration supports progression of Epilepsy Gene Therapy toward clinical trials CombiGene AB (publ) (“CombiGene”), a leading
CombiGene AB (publ) (“CombiGene”) has today entered an inlicensing and collaboration agreement with Lipigon Pharmaceuticals AB’s
The Offer is not being made, and this press release may not be distributed, directly or
CombiGene concludes the offer to the shareholders and the holders of warrants in Panion, ends the
• When the initial acceptance period was due, the shareholders in Panion had accepted to transfer
CombiGene AB (publ) (“CombiGene”) today announces a public offer to the holders of shares (“Shares”) and